FDA Approves Farydak (Panobinostat) for Multiple Myeloma
The US Food and Drug Administration (FDA) has approved Farydak (panobinostat) for people with multiple myeloma.
FDA Approves Generic Version of Doxil to Address Shortage
The US Food and Drug Administration (FDA) has approved the first generic version of the cancer drug Doxil (doxorubicin liposome).
Report Studies Link between World Trade Center Exposure and Cancer Risk
A study of people exposed to Ground Zero has found that early responders and recovery workers at site of the World Trade Center terrorist attack do not appear to have an increased risk of cancer overall thus far.